AIR DNase
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Protalix
Overview
AIR DNase is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AIR DNase clinical trials
Explore related
Medical disclaimer. This page summarizes research about AIR DNase for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.